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• Diagnosis of AF is based off confirmed ECG characteristics . ECG Characteristics 
include:
• No p waves
• Low-amplitude fibrillatory waves
• Irregularly irregular R-R interval
(McCance & Huether, 2018)
• Identification of patients who are asymptomatic is challenging and may be 
improved through increased and improved community screening (McCance & 
Huether, 2018).
• A diagnosis of AF increases the patient’s risk for AF by 5 times. Interestingly, 
every 5th stroke that is diagnosed can be attributed to AF (Bielecka et. al., 2021).
• The CHA2DS2-VASC scale can be used to assess risk for thromboembolism in 
patients diagnosed with AF. A score on the scale of ≥2 for men and ≥3 for women 
indicates that the patient should be considered for oral anticoagulation therapy 
to prevent risk of stroke (Bielecka et. al., 2021).
• There are four classifications of AF diagnosis based on how often the rhythm 
occurs and how it responds to treatment. (National Heart, Lung, and Blood 
Institute, n.d)
• Paroxysmal AF: brief occurrences of AF that may last up to a week 
but go away on their own. Patient may display symptoms or be 
asymptomatic.
• Persistent AF: continuous AF that lasts greater than a week.
• Long-term persistent AF: last longer that a year without going 
away.
• Permanent AF: does not go away even after treatments.
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Figure 3: Scan the QR code with a 
mobile device to view an animated 
GIF provided by the CDC that shows 
a comparison of telemetry and  
heart mechanics between sinus and 
atrial fibrillation rhythms.
• Atrial Fibrillation (AF) is the most 
diagnosed heart arrhythmia with 
future projections estimating that 
12.1 million people in the United 
States will be diagnosed with AF 
by 2030 (Colilla et. al., 2013).
• Patients who develop AF are at 
increased risk for stroke, heart 
failure, hospitalization, and death 
(Ganz & Spragg, 2021).
• 15% to 25% of stroke patients 
have AF as a risk factor (McCance 
& Huether, 2018).
• Cardiologist rate AF as one of the 
most difficult arrhythmias to treat 
(Jacob, 2017).
• AF was selected as a poster topic 
as education for clinicians and 
patients is essential in diagnosing, 
treating, and preventing AF. 





















• History of myocardial infarction
• Hyperthyroidism





Figure 1 retrieved from 
https://my.clevelandclinic.org/health/diseases/16765-atrial-fibrillation-afib
Underlying PathophysiologyDiagnosis Treatments
• For acute AF, first treat the underlying problem such as electrolyte disturbances, 
decrease adrenergic medications, treat blood pressure, treat pain and anxiety.
• Management of AF focuses on four things including management of 
cardiovascular risk factors, rate control, rhythm control, and anticoagulation if the 
patient is at risk for thromboembolism (Jacob, 2017).
• Rate control aims to lower the ventricular response in AF by slowing AV nodal 
conduction with agents such as beta blockers, calcium channel blockers, and 
digoxin (Depoorter et. al., 2019).
• Rhythm control aims to restore and maintain sinus rhythm of the heart with the 
use of antiarrhythmic medications, electrical cardioversion, percutaneous catheter 
ablation, or other surgical procedure (Kumar, 2021).
• Thromboembolism prophylaxis with direct acting oral anticoagulants should be 
considered for patients with AF based on their CHA2DS2-VASC scale score and 
overall clinical picture (Bielecka et. al., 2021).
• It is important to be able to identify AF on telemetry and to make clinical 
decisions that decrease the risks associated with the diagnosis.
• Educate patients on decreasing health risk factors that could lead to the 
development of AF.
• Understand that prevention of thromboembolism with anticoagulants is 
important in patients with AF.
• Studies have not determined whether rate control vs rhythm control produces 
better outcomes in patients with AF (Depoorter et. al., 2019).
CHA2DS2-VASC Scale
C Congestive heart failure 1
H Hypertension 1
A2 Age ≥ 75 years 2
D Diabetes 1
S2 History Stroke/ TIA/ thromboembolism 2
V Vascular disease 1
A Age of 65-74 years 1
SC Sex = female 1
• In normal physiology, electrical transduction from the heart starts in the SA node 
and travels down to the AV node before conducting an impulse across the 
ventricles. In AF, the electrical transduction in the atria is chaotic and unorganized 
due to several possible reasons such as atrial remodeling, elevated atrial pressures, 
and inflammation of the atria (Ganz, 2021). 
• Atrial remodeling can be divided into three different types including structural, 
electrical, and autonomic (Wysokiński et. al., 2020).
• Structural remodeling of the atria is caused when there is a dissociation between 
the electric activity of the atria and the muscle fibers. This can be caused by fibrosis 
and cellular hypertrophy of the cardiomyocytes (Wysokiński et. al., 2020). 
• Electrical remodeling in the atria can cause AF by shortening the resting membrane 
potential and refractory periods of the cardiomyocytes (Wysokiński et. al., 2020). 
One of the main “triggers” of rapidly discharging and unorganized electrical 
impulses can come from the pulmonary veins (Hassanabad et. al., 2019).
• Increased levels of atrial natriuretic peptide, angiotensin II, and transforming 
growth factor are all neurohormonal changes related to the pathophysiology of AF 
(Wysokiński et. al., 2020). 
• Due to blood not flowing as well as it should because of the chaotic and quivering 
atria, a patient with AF is at a significantly increased risk to develop an atrial 
thrombus which could cause stroke (CDC,  2020).
• Assessing the need for oral anticoagulation to decrease risk of stroke is essential. 
The CHA2DS2-VASC  scale can be used to evaluate this risk (Bielecka et. al., 2021).
• Neurohormonal changes that attribute to AF are due to a number of reasons 
including hypertension. Prevention of hypertension leads to decreased risk of 
developing AF (Wysokiński et. al., 2020). 
• Overall, AF has a huge impact on 
healthcare and the importance of 
education for the prevention, 
diagnosis, and treatment for 
clinicians and patients cannot be 
overstated.
• Prevention of thromboembolism 
is essential in preventing stroke 
since patients with AF are at a 
significantly increased risk.
• Risk factor management is key in 
decreasing the incidence of AF 
and for preventing complications 
caused by AF. Nurse-led 
community clinics have been 
found to prevent hospitalizations 
from AF by allowing for 
improved risk factor 
management, improved 
coordination among healthcare 
providers, and improved 
management of patients with the 
diagnosis (Jacob, 2017).
Figure 2 adapted from (Bielecka et. al., 2021)
Figure 4 shows catheter ablation technique to isolate the pulmonary veins on the left 
and AV node ablation on the right for the treatment of AF. Images retrieved from 
https://www.mayoclinic.org/diseases-conditions/atrial-fibrillation/diagnosis-
treatment/drc-20350630
